CUSIP: 00162Q593
Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
1,438,262
-
Share change
-
+142,784
-
Total reported value
-
$51,309,167
-
Put/Call ratio
-
15%
-
Price per share
-
$35.75
-
Number of holders
-
37
-
Value change
-
+$5,137,206
-
Number of buys
-
15
-
Number of sells
-
12
Security key
00162Q593
Report period
Q1 2024
Institutions
37
Top holders
10
Reporting periods
Holder history for CUSIP 00162Q593
Recent filing periods:
Top shareholders of SBIO - ALPS ETF TR - MED BREAKTHGH (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q1 2024
As of 31 Mar 2024,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,438,262 shares.
The largest 10 holders included
DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, NTV Asset Management LLC, Phoenix Wealth Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Strategic Financial Services, Inc,, and LPL Financial LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q1 2024 vs Q4 2023 Across Filers
| Investor |
Q4 2023 Shares |
Q1 2024 Shares |
Share Diff |
Share Chg % |
Q4 2023 Value $ |
Q1 2024 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.